Skip to the reading

Colorado Peptide care questions

A reader’s edition

How can I tell what is established?

A page calls a peptide “proven” and points to a government database. Ask what the record actually establishes before treating it as an answer.

Ask for the exact product and proposed use

Semaglutide (Ozempic, Wegovy) has FDA-approved products for specified uses. Approval of a named product does not give an approval to a compounded version of it.

An FDA-approved product is one whose evidence the Food and Drug Administration has reviewed for a named use. That agency name is often shortened to FDA.

Online offers may name peptides such as ipamorelin, retatrutide or BPC-157. The September 26, 2026 search of FDA records found no US-approved medicines containing any of those three. The search found no application asking FDA to approve them. That result does not, by itself, say whether a pharmacy may make one to order.

Ask which health problem the offer claims to address and what supports that claim. Ask separately whether the pharmacy may legally prepare the exact medicine.

For retatrutide, FDA’s September 2026 position is clear: federal law does not allow compounding it. FDA has found no condition for which retatrutide is safe and effective.

Read the record before the headline

Does a government drug code mean approval?Reveal the distinction

A product’s number in the FDA drug list is its NDC, short for National Drug Code. Having that number or a place in the list does not mean FDA approved the medicine.

  • Is this evidence about the exact preparation being offered?
  • Does it address the same health problem?
  • Who took part, and what was the comparison?
  • What did the authors leave uncertain?
  • Which conclusion is the clinician drawing from it?

Keep an approval record, a research paper and a marketing claim in separate parts of your notes. Ask the clinician to explain the connection between them.